Kymera Therapeutics
Price & Volume
Stats
See more52W Range | $19.44-$53.27 |
Market Cap | $2.1B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $47M |
Revenue Growth (YoY) | -84.6% |
Gross Profit (12 Mos) | -$193.1M |
Diluted EPS | -$2.98 |
News
See moreYahoo Finance • 5 days ago
Kymera Therapeutics Announces First Patient Dosed in BROADEN Phase 1b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class Oral STAT6 Degrader
Yahoo Finance • 2 months ago
NAYA Biosciences Announces Nomination of New Board Members
Yahoo Finance • 3 months ago
Kymera Therapeutics to Participate in Upcoming February Investor Conferences
About
CEO | Dr. Nello Mainolfi M.D., Ph.D. |
Address | 500 North Beacon Street, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 188 |
